Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    chTNT-1/B
Show Display Options
Rank Status Study
1 Completed Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
Condition: Glioblastoma Multiforme
Intervention: Drug: 131I-chTNT-1/B MAb (Cotara)
2 Completed Targeted Internal Radiation Therapy in Advanced HCC Patients.
Conditions: Internal Radiation;   Advanced Hepatocellular Carcinoma
Intervention: Biological: 131I-chTNT-1/B
3 Completed Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Intervention: Drug: 131-I-chTNT-1/B MAB
4 Completed Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Intervention: Radiation: iodine I 131 monoclonal antibody TNT-1/B
5 Completed Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: conventional surgery;   Radiation: iodine I 131 monoclonal antibody TNT-1/B

Study has passed its completion date and status has not been verified in more than two years.